EXHIBIT 107
Calculation of Filing Fee Table
FORM S-8
(Form Type)
Pyxis Oncology, Inc.
(Exact Name of Registrant as Specified in its Charter)
Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee(2) | |||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.001 per share | Rules 457(c) and 457(h) | 1,400,000 | $2.28 | $3,192,000.00 | .0000927 | $295.90 | ||||||||
Total Offering Amounts | $295.90 | |||||||||||||||
Total Fee Offsets | — | |||||||||||||||
Net Fee Due | $295.90 |
(1) | Pyxis Oncology, Inc. (the “Registrant”) is filing this Registration Statement to register 1,400,000 shares of common stock, $0.001 par value per share (“Common Stock”), for issuance under the Pyxis Oncology, Inc. 2022 Inducement Plan (the “Plan”). Pursuant to Rule 416 of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers any additional shares of Registrant’s Common Stock that become issuable under the plan set forth herein by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of Registrant’s Common Stock, as applicable. |
(2) | Estimated in accordance with Rules 457(c) and 457(h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $2.28 per share, the average of the high and low prices of the Registrant’s Common Stock on June 28, 2022 as reported on the Nasdaq Global Market. |